PI3K/Akt/mTOR_Chem Catch, Global Inhibitor Store

Home About Us Newest Recommend

Search

Search Type： Product Name, Cat No., CAS No., Chemical Name

Your Position: Home > PI3K/Akt/mTOR

All Categories

Angiogenesis

Apoptosis

Autophagy

Cell Cycle

Cytoskeletal Signaling

DNA Damage

Endocrinology & Hormones

Epigenetics

GPCR & G Protein

Immunology & Inflammation

JAK/STAT

kit

MAPK

Metabolism

Microbiology

Neuronal Signaling

NF-κB

Others

PI3K/Akt/mTOR

Proteases

Protein Tyrosine Kinase

Stem Cells & Wnt

TGF-beta/Smad

Transmembrane Transporters

Ubiquitin

PI3K/Akt/mTOR

GSK-3 inhibitor Akt inhibitor AMPK activator PI3K inhibitor ATM/ATR inhibitor mTOR inhibitor mTOR activator S6 Kinase inhibitor PDK inhibitor ATM/ATR activator AMPK inhibitor PKA inhibitor DNA-PK inhibitor MELK inhibitor Akt activator PI3K activator

Goods List

Cat#

Goods Name

description

PIK-293 is a PI3K inhibitor, mostly for PI3Kδ with IC50 of 0.24 μM, 500-, 100- and 50-fold less potent to PI3Kα/β/γ, respectively.

Pictilisib (GDC-0941)

Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM in cell-free assays, with modest selectivity against p110β (11-fold) and p110γ (25-fold). Phase 2.

PI-3065 is a selective p110δ inhibitor with IC50 of 15 nM, >70-fold selectivity over other PI3K family members.

PI-103 is a multi-targeted PI3K inhibitor for p110α/β/δ/γ with IC50 of 2 nM/3 nM/3 nM/15 nM in cell-free assays, less potent to mTOR/DNA-PK with IC50 of 30 nM/23 nM.

PHT-427 is a dual Akt and PDPK1 inhibitor (high affinity binding for the PH domains of Akt and PDPK1) with K_i of 2.7 μM and 5.2 μM, respectively.

Phenformin HCl is a hydrochloride salt of phenformin that is an anti-diabetic drug from the biguanide class. It activates AMPK, increasing activity and phosphorylation.

PF-4989216 is a potent and selective PI3K inhibitor with IC50 of 2 nM, 142 nM, 65 nM, 1 nM, and 110 nM for p110α, p110β, p110γ, p110δ, and VPS34, respectively.

PF-4708671 is a cell-permeable inhibitor of p70 ribosomal S6 kinase (S6K1 isoform) with K_i/IC50 of 20 nM/160 nM in cell-free assays, 400-fold greater selectivity for S6K1 than S6K2, and 4- and >20-fold selectivity for S6K1

PF-04691502 is an ATP-competitive PI3K(α/β/δ/γ)/mTOR dual inhibitor with K_i of 1.8 nM/2.1 nM/1.6 nM/1.9 nM and 16 nM in cell-free assays, little activity against either Vps34, AKT, PDK1, p70S6K, MEK, ERK, p38, or JNK. Phase 2.

Perifosine (KRX-0401)

Perifosine (KRX-0401) is a novel Akt inhibitor with IC50 of 4.7 μM in MM.1S cells, targets pleckstrin homology domain of Akt. Phase 3.

Chem Catch products are for research use only. Not for human use. We do not sell to patients.

沪ICP备16042327号-2